Helping Doctors Share in Price-Discounted Contracts
One of the problems large, national hospital groups have run into in doing contracts for physician-preferred products is that physicians themselves don't share in the savings that result from their willingness to compromise product choice. Now some product companies are looking for ways to let physicians benefit as well, without triggering fraud and abuse regulations.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.